Year |
Citation |
Score |
2021 |
Li J, Pohl L, Schüler J, Korzeniewski N, Reimold P, Kaczorowski A, Hou W, Zschäbitz S, Nientiedt C, Jäger D, Hohenfellner M, Duensing A, Duensing S. Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery. Biomedicines. 9. PMID 34072926 DOI: 10.3390/biomedicines9060627 |
0.521 |
|
2019 |
Tapia-Laliena MÁ, Korzeniewski N, Peña-Llopis S, Scholl C, Fröhling S, Hohenfellner M, Duensing A, Duensing S. Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability. Oncogenesis. 8: 4. PMID 30631037 DOI: 10.1038/s41389-018-0110-2 |
0.593 |
|
2016 |
Hoefflin R, Lahrmann B, Warsow G, Hübschmann D, Spath C, Walter B, Chen X, Hofer L, Macher-Goeppinger S, Tolstov Y, Korzeniewski N, Duensing A, Grüllich C, Jäger D, Perner S, et al. Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity. Nature Communications. 7: ncomms11845. PMID 27291893 DOI: 10.1038/Ncomms11845 |
0.586 |
|
2015 |
Mang J, Korzeniewski N, Dietrich D, Sailer V, Tolstov Y, Searcy S, von Hardenberg J, Perner S, Kristiansen G, Marx A, Roth W, Herpel E, Grüllich C, Popeneciu V, Pahernik S, et al. Prognostic Significance and Functional Role of CEP57 in Prostate Cancer. Translational Oncology. 8: 487-96. PMID 26692530 DOI: 10.1016/J.Tranon.2015.11.004 |
0.651 |
|
2015 |
Korzeniewski N, Tosev G, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S. Identification of cell-free microRNAs in the urine of patients with prostate cancer. Urologic Oncology. 33: 16.e17-22. PMID 25445383 DOI: 10.1016/J.Urolonc.2014.09.015 |
0.602 |
|
2015 |
Schneider M, Korzeniewski N, Merkle K, Schüler J, Grüllich C, Hadaschik B, Hohenfellner M, Duensing S. The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal-Implications for targeted therapies. Urologic Oncology. 33: 72.e1-7. PMID 24996772 DOI: 10.1016/J.Urolonc.2014.06.001 |
0.631 |
|
2014 |
Georgi B, Korzeniewski N, Hadaschik B, Grüllich C, Roth W, Sültmann H, Pahernik S, Hohenfellner M, Duensing S. Evolving therapeutic concepts in prostate cancer based on genome-wide analyses (review). International Journal of Oncology. 45: 1337-44. PMID 25070358 DOI: 10.3892/Ijo.2014.2567 |
0.61 |
|
2014 |
Tapia-Laliena MA, Korzeniewski N, Hohenfellner M, Duensing S. High-risk prostate cancer: a disease of genomic instability. Urologic Oncology. 32: 1101-7. PMID 24931269 DOI: 10.1016/J.Urolonc.2014.02.005 |
0.614 |
|
2014 |
Schneider M, Schüler J, Höfflin R, Korzeniewski N, Grüllich C, Roth W, Teber D, Hadaschik B, Pahernik S, Hohenfellner M, Duensing S. Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma. Urologic Oncology. 32: 877-84. PMID 24929890 DOI: 10.1016/J.Urolonc.2014.03.011 |
0.589 |
|
2014 |
Boichuk S, Lee DJ, Mehalek KR, Makielski KR, Wozniak A, Seneviratne DS, Korzeniewski N, Cuevas R, Parry JA, Brown MF, Zewe J, Taguchi T, Kuan SF, Schöffski P, Debiec-Rychter M, et al. Unbiased compound screening identifies unexpected drug sensitivities and novel treatment options for gastrointestinal stromal tumors. Cancer Research. 74: 1200-13. PMID 24385214 DOI: 10.1158/0008-5472.Can-13-1955 |
0.347 |
|
2013 |
Boichuk S, Parry JA, Makielski KR, Litovchick L, Baron JL, Zewe JP, Wozniak A, Mehalek KR, Korzeniewski N, Seneviratne DS, Schöffski P, Debiec-Rychter M, DeCaprio JA, Duensing A. The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance imatinib-induced apoptosis. Cancer Research. 73: 5120-9. PMID 23786773 DOI: 10.1158/0008-5472.Can-13-0579 |
0.357 |
|
2013 |
Cuevas R, Korzeniewski N, Tolstov Y, Hohenfellner M, Duensing S. FGF-2 disrupts mitotic stability in prostate cancer through the intracellular trafficking protein CEP57. Cancer Research. 73: 1400-10. PMID 23243019 DOI: 10.1158/0008-5472.Can-12-1857 |
0.646 |
|
2013 |
Korzeniewski N, Hohenfellner M, Duensing S. The centrosome as potential target for cancer therapy and prevention. Expert Opinion On Therapeutic Targets. 17: 43-52. PMID 23062185 DOI: 10.1517/14728222.2013.731396 |
0.64 |
|
2012 |
Korzeniewski N, Hohenfellner M, Duensing S. CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer. Neoplasia (New York, N.Y.). 14: 799-806. PMID 23019411 DOI: 10.1593/Neo.12580 |
0.667 |
|
2012 |
Li J, Kim S, Kobayashi T, Liang FX, Korzeniewski N, Duensing S, Dynlacht BD. Neurl4, a novel daughter centriole protein, prevents formation of ectopic microtubule organizing centres. Embo Reports. 13: 547-53. PMID 22441691 DOI: 10.1038/Embor.2012.40 |
0.564 |
|
2011 |
Korzeniewski N, Treat B, Duensing S. The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression. Molecular Cancer. 10: 61. PMID 21609466 DOI: 10.1186/1476-4598-10-61 |
0.662 |
|
2011 |
Korzeniewski N, Spardy N, Duensing A, Duensing S. Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Letters. 305: 113-22. PMID 21075512 DOI: 10.1016/J.Canlet.2010.10.013 |
0.715 |
|
2010 |
Korzeniewski N, Cuevas R, Duensing A, Duensing S. Daughter centriole elongation is controlled by proteolysis. Molecular Biology of the Cell. 21: 3942-51. PMID 20861314 DOI: 10.1091/Mbc.E09-12-1049 |
0.595 |
|
2010 |
Korzeniewski N, Wheeler S, Chatterjee P, Duensing A, Duensing S. A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention. Molecular Cancer. 9: 153. PMID 20565777 DOI: 10.1186/1476-4598-9-153 |
0.643 |
|
2010 |
Korzeniewski N, Duensing A, Duensing S. Abstract 5354: HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of PLK4, a master regulator of centriole biogenesis Cancer Research. 70: 5354-5354. DOI: 10.1158/1538-7445.Am10-5354 |
0.687 |
|
2009 |
Korzeniewski N, Zheng L, Cuevas R, Parry J, Chatterjee P, Anderton B, Duensing A, Münger K, Duensing S. Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating polo-like kinase 4 protein levels. Cancer Research. 69: 6668-75. PMID 19679553 DOI: 10.1158/0008-5472.Can-09-1284 |
0.646 |
|
2009 |
Duensing A, Spardy N, Chatterjee P, Zheng L, Parry J, Cuevas R, Korzeniewski N, Duensing S. Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environmental and Molecular Mutagenesis. 50: 741-7. PMID 19326465 DOI: 10.1002/Em.20478 |
0.711 |
|
Show low-probability matches. |